Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
04/2014
04/30/2014CN102716120B Application of (3R)-des-O-methyl lasiodiplodin in preparation of drugs for preventing or treating depression
04/30/2014CN102633731B 6-quinoxaline formic acid amide compounds, preparation method and application thereof
04/30/2014CN102558157B Ethoxyl-triazole compound or amonoethyl-triazole compound and preparation method and application thereof
04/30/2014CN102526403B Chinese medicinal preparation for treating facial nerve paralysis
04/30/2014CN102491929B 1-hydroxy-2-ketopyrrolidine compound and preparation method and application thereof
04/30/2014CN102272081B Tetrahydronaphthalen-2-ol derivatives
04/30/2014CN102212111B Micromolecule polypeptide and micromolecule polypeptide liposome as well as applications thereof
04/30/2014CN102153498B Resveratrol analogue and preparation method and application thereof
04/30/2014CN101945876B Nitrogen-containing bicyclic compounds active on chronic pain conditions
04/30/2014CN101910126B Proline analogs as ligands for cannabinoid receptors for the treatment of pain
04/30/2014CN101843897B Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders
04/30/2014CN101602786B N<6>-substituted adenosine derivative, preparation method thereof, drug composition and application
04/29/2014US8710178 Macrocyclic cysteine protease inhibitors and compositions thereof
04/29/2014US8710095 Drugs for prophylaxis or mitigation of taxane-induced neurotoxicity
04/29/2014US8710074 Dihydronaphthyridinyl(organo)methanone analogs as positive allosteric mGluR5 modulators
04/29/2014US8710072 Morphinan compounds
04/29/2014US8710047 5-HT3 receptor modulators, methods of making, and use thereof
04/29/2014US8710046 5-HT3 receptor modulators, methods of making, and use thereof
04/29/2014US8710040 Pharmaceutical composition comprising gabapentin or an analogue thereof and an α-aminoamide and its analgesic use
04/29/2014US8710008 Compounds, compositions and use
04/29/2014US8709485 Pharmaceutical compositions of entacapone, levodopa and carbidopa with improved bioavailability
04/29/2014US8709422 Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
04/29/2014US8709406 Prevention and treatment of oxidative stress disorders by gluthathione and phase II detoxification enzymes
04/29/2014CA2791389C Amino -dihydrooxazine and amino - dihydrothiazine spiro compounds as beta - secretase modulators and their medical use
04/29/2014CA2721007C Derivatives of galantamine as pro-drugs for the treatment of human brain diseases
04/29/2014CA2664126C The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of cns disorders
04/29/2014CA2655573C Therapeutic or prophylactic agent for multiple sclerosis
04/29/2014CA2602075C N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use
04/29/2014CA2594203C Use of a vanilloid receptor agonist together with a glycosaminoglycan or proteoglycan for producing an agent for treating articular pain and method for applying said agent
04/29/2014CA2554809C Novel n-alkyl thiourea-and thioamide-substituted imidazolyl inhibitors and glutaminyl cyclase
04/29/2014CA2408571C Mammalian receptor proteins; related reagents and methods
04/29/2014CA2400485C Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
04/26/2014CA2829371A1 Methods for preventing and treating post-traumatic stress disorder (ptsd)
04/24/2014WO2014063087A1 Treating tumors of the central nervous system
04/24/2014WO2014063071A1 Treatment of depression and ptsd
04/24/2014WO2014063057A1 Compositions and methods for the treatment of parkinson's disease
04/24/2014WO2014062548A1 Tetrahydroimdidazopyrazine derivatives as cgrp receptor antagonists
04/24/2014WO2014062044A1 Fluorinated benzenesulfonamides as inhibitors of carbonic anhydrase
04/24/2014WO2014061764A1 Xanthene derivative
04/24/2014WO2014061735A1 NOVEL HIGH-FUNCTIONING ENZYME HAVING ALTERED HUMAN β-HEXOSAMINIDASE B SUBSTRATE SPECIFICITY, AND HAVING PROTEASE RESISTANCE APPLIED THERETO
04/24/2014WO2014061693A1 Novel non-aromatic carbocyclic or non-aromatic heterocyclic derivative
04/24/2014WO2014061676A1 Heterocyclic compound
04/24/2014WO2014060509A1 Use of a bioactivated phytochemical as a neuroprotective agent for preventing and treating disorders related to nervous system
04/24/2014WO2014060501A1 Agent for alleviating or treating migraine pain
04/24/2014WO2014060432A1 Pyrrolotriazinone derivatives as pi3k inhibitors
04/24/2014WO2014060431A1 Pyrrolotriazinone derivatives as pi3k inhibitors
04/24/2014WO2014060398A1 Ethynyl derivatives as modulators of mglur5 receptor activity
04/24/2014WO2014060394A1 Ethynyl derivatives as modulators of mglur5 receptor activity
04/24/2014WO2014060386A1 Indol-amide compounds as beta-amyloid inhbitors
04/24/2014WO2014060384A1 Ethynyl derivatives as modulators of mglur5 receptor activity
04/24/2014WO2014060371A1 Inhibitors of syk
04/24/2014WO2014060113A1 Novel kinase inhibitors
04/24/2014WO2014060112A1 Pyrazolo[4,3-d]pyrimidines as kinase inhibitors
04/24/2014WO2014059702A1 Benfotiamine polymorphs, preparation method and use thereof
04/24/2014WO2014059558A1 Durable analgetic sebacoyl dinalbuphine ester-plga controlled release formulation
04/24/2014WO2014059512A1 Oral drug delivery formulations
04/24/2014WO2014020480A3 Compositions and methods for the treatment migraine and neurologic diseases
04/24/2014WO2014006529A3 Compositions and methods for the treatment of moderate to severe pain
04/24/2014WO2013049362A8 Method of treating multiple sclerosis by intrathecal depletion of b cells and biomarkers to select patients with progressive multiple sclerosis
04/24/2014US20140113969 Preventing And/Or Treating Cardiovascular Disease And/Or Associated Heart Failure
04/24/2014US20140113893 Highly Concentrated Stable Meloxicam Solutions for Needleless Injection
04/24/2014US20140113878 Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
04/24/2014US20140112981 Controlled release hydrocodone formulations
04/24/2014DE102012110009A1 Mittel zur Linderung oder gegen Migräneschmerzen Means for alleviating or migraine pain
04/24/2014DE102012020542A1 Use of an active ingredient consisting of e.g. tocotrienols in the substantial absence of tocopherols, for the prevention or treatment of e.g. normal or pathological inflammatory diseases, pain, diseases of nervous system, and cancer
04/23/2014EP2722386A1 Crushed cells and composition thereof
04/23/2014EP2722329A1 Indol-amide compounds as beta-amyloid inhbitors
04/23/2014EP2721012A1 Bicyclo (3.1.0) hexane- 2, 6 -dicarboxylic acid derivatives as mglu2 receptor agonist
04/23/2014EP2721011A1 Prostaglandin receptor ep2 antagonists, derivatives, compositions, and uses related thereto
04/23/2014EP2720989A1 Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia
04/23/2014EP2720698A1 Method of administration of 4-((1r,3s)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and the salts thereof in the treatment of schizophrenia
04/23/2014EP2720693A1 Chromane-like cyclic prenylflavonoids for the medical intervention in neurological disorders
04/23/2014EP2720692A2 Cathepsin inhibitors for treating microglia-mediated neuron loss in the central nervous system
04/23/2014CN103748087A Indazole- and pyrrolopyridine-derivative and pharmaceutical use thereof
04/23/2014CN103748086A Pyridine-and pyrazine derivatives
04/23/2014CN103748079A Pyridazinone compounds and their use as DAAO inhibitors
04/23/2014CN103747791A Honey composition with l-alanyl- l- glutamine
04/23/2014CN103740713A Complement antagonists and uses thereof
04/23/2014CN103740645A Preparation of neural stem cell-derived Exosomes, and application of neural stem cell-derived Exosomes in nervous system diseases
04/23/2014CN103739716A Fused polypeptide with function of protecting dynamic equilibrium of nerve cell mitochondria and application thereof
04/23/2014CN103739647A Non-hormonal steroid modulators of nf-kb for treatment of disease
04/23/2014CN103739642A Carbamate derivates of scutellarin and seutellarein, and application thereof
04/23/2014CN103739605A Imaging agents for detecting neurological disorders
04/23/2014CN103739553A N-substituted imidazolecarboxylic acid ester chiral compound containing ether side chain, preparation method and application thereof
04/23/2014CN103739531A Novel amino acid derivatives, method for preparing same, and therapeutic use thereof
04/23/2014CN103739499A Quinone based nitric oxide donating compounds
04/23/2014CN103736085A Medicament for preventing and treating alzheimer disease
04/23/2014CN103736046A Medicament rod for treating shoulder-hand syndrome after stroke and preparation method thereof
04/23/2014CN103736041A Drug for treating schizophrenia and preparation method thereof
04/23/2014CN103736033A Infantile convulsions tincture for dredging channels and expelling wind-damp
04/23/2014CN103736027A Traditional Chinese medicine composition for treating insomnia
04/23/2014CN103736019A Traditional Chinese medicinal preparation for treating insomnia and dreamful sleep
04/23/2014CN103736017A Traditional Chinese medicine composition for treating intercostal neuralgia and preparation method of traditional Chinese medicine composition
04/23/2014CN103736001A Traditional Chinese medicine composition for treating insomnia
04/23/2014CN103735977A Traditional Chinese medicine for treating female prosopospasm and preparation method thereof
04/23/2014CN103735975A External medicinal composition for treating nerve headache
04/23/2014CN103735973A Traditional Chinese medicine composition for improving memory and preparation method thereof
04/23/2014CN103735954A Traditional Chinese medicine formula for treating insomnia
04/23/2014CN103735941A Mind easing and sleeping decoction
04/23/2014CN103735936A A traditional Chinese medicine used for trading anorexia nervosa
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 1833